| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30082832 | HIV | ENSG00000153904.21 | protein_coding | DDAH1 | No | No | 23576 | B1AKK2 B4DYP1 O94760 |
| TVIS30024233 | HIV | ENSG00000153904.21 | protein_coding | DDAH1 | No | No | 23576 | B1AKK2 B4DYP1 O94760 |
| TVIS30024234 | HIV | ENSG00000153904.21 | protein_coding | DDAH1 | No | No | 23576 | B1AKK2 B4DYP1 O94760 |
| TVIS30024235 | HIV | ENSG00000153904.21 | protein_coding | DDAH1 | No | No | 23576 | B1AKK2 B4DYP1 O94760 |
| TVIS30024236 | HIV | ENSG00000153904.21 | protein_coding | DDAH1 | No | No | 23576 | B1AKK2 B4DYP1 O94760 |
| TVIS30024237 | HIV | ENSG00000153904.21 | protein_coding | DDAH1 | No | No | 23576 | B1AKK2 B4DYP1 O94760 |
| TVIS20030001 | HPV | ENSG00000153904.21 | protein_coding | DDAH1 | No | No | 23576 | B1AKK2 B4DYP1 O94760 |
| TVIS20047226 | HPV | ENSG00000153904.21 | protein_coding | DDAH1 | No | No | 23576 | B1AKK2 B4DYP1 O94760 |
| TVIS20047623 | HPV | ENSG00000153904.21 | protein_coding | DDAH1 | No | No | 23576 | B1AKK2 B4DYP1 O94760 |
| TVIS44032857 | HTLV-1 | ENSG00000153904.21 | protein_coding | DDAH1 | No | No | 23576 | B1AKK2 B4DYP1 O94760 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | DDAH1 |
|---|---|
| DrugBank ID | DB05351 |
| Drug Name | Dexlansoprazole |
| Target ID | BE0000766 |
| UniProt ID | O94760 |
| Regulation Type | |
| PubMed IDs | 23825361; 28588208 |
| Citations | Ghebremariam YT, LePendu P, Lee JC, Erlanson DA, Slaviero A, Shah NH, Leiper J, Cooke JP: Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine. Circulation. 2013 Aug 20;128(8):845-53. doi: 10.1161/CIRCULATIONAHA.113.003602. Epub 2013 Jul 3.@@Tommasi S, Elliot DJ, Hulin JA, Lewis BC, McEvoy M, Mangoni AA: Human dimethylarginine dimethylaminohydrolase 1 inhibition by proton pump inhibitors and the cardiovascular risk marker asymmetric dimethylarginine: in vitro and in vivo significance. Sci Rep. 2017 Jun 6;7(1):2871. doi: 10.1038/s41598-017-03069-1. |
| Groups | Approved; Investigational |
| Direct Classification | Sulfinylbenzimidazoles |
| SMILES | CC1=C(OCC(F)(F)F)C=CN=C1C[S@@](=O)C1=NC2=CC=CC=C2N1 |
| Pathways | |
| PharmGKB | PA166110257 |
| ChEMBL | CHEMBL1201863 |
